1. Home
  2. SOWG vs CSBR Comparison

SOWG vs CSBR Comparison

Compare SOWG & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sow Good Inc.

SOWG

Sow Good Inc.

HOLD

Current Price

$3.23

Market Cap

69.9M

ML Signal

HOLD

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$5.10

Market Cap

81.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOWG
CSBR
Founded
2010
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.9M
81.0M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
SOWG
CSBR
Price
$3.23
$5.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.9K
7.2K
Earning Date
05-15-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,900,000.00
Revenue This Year
N/A
$4.84
Revenue Next Year
N/A
$11.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$4.83
52 Week High
$4.45
$8.74

Technical Indicators

Market Signals
Indicator
SOWG
CSBR
Relative Strength Index (RSI) 47.29 51.99
Support Level $2.45 $4.83
Resistance Level $3.65 $6.31
Average True Range (ATR) 0.27 0.20
MACD -0.01 0.05
Stochastic Oscillator 5.28 62.12

Price Performance

Historical Comparison
SOWG
CSBR

About SOWG Sow Good Inc.

Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats. The company operates in one reportable segment, reflecting its capital-light business model under which it earns proceeds from the sale of freeze-dried candy products.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: